Long-term immunogenicity of an inactivated virosome hepatitis A vaccine.
about
Liposomal Formulations in Clinical Use: An Updated Review.Immunogenicity and safety of a pediatric dose of a virosomal hepatitis A vaccine in healthy children in India.Hepatitis A vaccines.Virosomal adjuvanted antigen delivery systems.Prevention of hepatitis A by vaccination.Hepatitis A vaccines: the growing case for universal immunisation of children.Prevention of hepatitis A by Havrix: a review.Review of 10 years of marketing experience with Chinese domestic inactivated hepatitis A vaccine Healive®Influenza virosomes as a combined vaccine carrier and adjuvant system for prophylactic and therapeutic immunizations.Epaxal: a virosomal vaccine to prevent hepatitis A infection.Comparison of immunogenicity and persistence between inactivated hepatitis A vaccine Healive® and Havrix® among children: A 5-year follow-up studyPredictors of durable immune responses six months after the last vaccination in preventive HIV vaccine trials.Travel health: routine, recommended and required vaccines.Model-based estimates of long-term persistence of induced HPV antibodies: a flexible subject-specific approach.Antibody persistence and immune memory in healthy adults following vaccination with a two-dose inactivated hepatitis A vaccine: long-term follow-up at 15 years.
P2860
Q33850427-845B90AA-59FC-4787-BFC3-B10565830530Q34291194-4585C143-C13A-4605-BC15-87795048F662Q34787404-8A1C08E2-4D66-47C6-93D1-48F985574CC3Q35192175-B26BFE1D-A2B4-4442-A999-083758BD8115Q35207528-59C94D9E-3412-438A-B160-C5D825449364Q36066059-A190B36E-D8BA-4682-B21F-4B647F2152AFQ36238689-53952876-E09E-4621-990E-8E0523F5F81AQ36849799-FEBCFAB9-F3DE-40CD-837F-F71F2B3BEFA7Q36968260-79E28FDF-FDA6-4ADE-9633-C2A757E5037CQ37290088-AE8022D1-71E5-4A77-8A45-098290884D20Q37375908-9E282729-1075-4A54-8560-71CD7567AADEQ38381606-118CA10D-00D1-4FB7-BB12-92C5B739A3FDQ39601034-1E719AF1-EDBC-4F39-B721-E4B587141858Q42243761-FB09C0EC-3D82-41A7-B053-8FD4BECAAD34Q50992687-8C373F26-0581-4A1F-9639-EDE6FA09B443
P2860
Long-term immunogenicity of an inactivated virosome hepatitis A vaccine.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Long-term immunogenicity of an inactivated virosome hepatitis A vaccine.
@en
Long-term immunogenicity of an inactivated virosome hepatitis A vaccine.
@nl
type
label
Long-term immunogenicity of an inactivated virosome hepatitis A vaccine.
@en
Long-term immunogenicity of an inactivated virosome hepatitis A vaccine.
@nl
prefLabel
Long-term immunogenicity of an inactivated virosome hepatitis A vaccine.
@en
Long-term immunogenicity of an inactivated virosome hepatitis A vaccine.
@nl
P2093
P2860
P356
P1476
Long-term immunogenicity of an inactivated virosome hepatitis A vaccine.
@en
P2093
P2860
P304
P356
10.1002/JMV.10244
P577
2002-12-01T00:00:00Z